Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05987553

The Influence of an E-learning Program on Recognition of Actinic Keratosis

The Influence of an E-learning Program on Recognition of Actinic Keratosis by General Practitioners). Implementation of Actinic Keratosis Guidelines Among General Practitioners.

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years – 67 Years
Healthy volunteers
Not accepted

Summary

The evaluation on the diagnostic accuracy of actinic keratosis recognition by general practitioners before and after participation on an e-learning program.

Detailed description

Actinic keratosis is defined as the most frequent common intra-epithelial neoplasm in the Caucasian population, with an increasing prevalence. If left untreated, actinic keratosis has the potency to develop into a cutaneous squamous-cell carcinoma. Treatment of actinic keratosis is aimed at both lesion reduction and to prevent malignant transformation. To achieve treatment adherence for patients, it is necessary to raise physician awareness about actinic keratosis. This study primarily aimed to investigate whether the sensitivity of establishing a correct actinic keratosis diagnosis by general practitioners (in training) would increase after participating in an e-learning program about the recognition of actinic keratosis. This was achieved by comparing the results of a pre- and post-test completed by general practitioners which was incorporated in the e-learning program.

Conditions

Interventions

TypeNameDescription
OTHERe-learning programAll participants participate in this intervention: an e-learning program about the recognition of actinic keratosis. The program exists of 30 cases. Each case exists of a question and thorough explanation including references to various sources.

Timeline

Start date
2021-01-01
Primary completion
2024-01-01
Completion
2025-12-01
First posted
2023-08-14
Last updated
2025-04-04

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05987553. Inclusion in this directory is not an endorsement.